Cargando…
The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer
BACKGROUND AND AIM: This study was aimed to reveal the clinical relevance and immune correlation of the SLC10 family genes in liver cancer. METHODS: A comprehensive bioinformatics analysis was utilized to determine the gene expression, genetic alterations, DNA methylation, clinical significance, sur...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809167/ https://www.ncbi.nlm.nih.gov/pubmed/36606115 http://dx.doi.org/10.2147/JHC.S392586 |
_version_ | 1784863066758840320 |
---|---|
author | Tian, Shan Li, Jiao Xiang, Jiankang Peng, Pailan |
author_facet | Tian, Shan Li, Jiao Xiang, Jiankang Peng, Pailan |
author_sort | Tian, Shan |
collection | PubMed |
description | BACKGROUND AND AIM: This study was aimed to reveal the clinical relevance and immune correlation of the SLC10 family genes in liver cancer. METHODS: A comprehensive bioinformatics analysis was utilized to determine the gene expression, genetic alterations, DNA methylation, clinical significance, survival association and immune correlation of seven SLC10 family genes in liver cancer. The multiplexed immunohistochemical technique was applied to determine the association between SLC10A3 protein expression and immune cells, and the correlation between SLC10A3 protein and immune checkpoints (PD1 and PD-L1) in a cohort of 32 individuals with liver cancer. RESULTS: The expression of SLC10 family genes was different between normal liver tissues and malignant liver tissues. SLC10A5 showed the highest alteration rate (8%), followed by SLC10A3 (2.8%). Low expression of SLC10A1 was indicative of poor tumor grade and advanced tumor stage in liver cancer. Scatter plots uncovered that expression of SLC10A3 was inversely associated with SLC10A1 and SLC10A5 expression in liver cancer. The expression of SLC10A1 and SLC10A5 was strongly associated with their DNA methylation. SLC10A1 expression was a reliable genetic biomarker for the prediction of survival outcomes in liver cancer population. Expression of SLC10 family genes was remarkably linked with the abundance of most immune infiltrating cells in liver cancer, and SLC10A3 was the most significant member. The multiplexed immunohistochemical technique confirmed that there existed the significant correlations between SLC10A3 protein expression and CD4 T cells, CD20 B cells and the close association with PD-1 in the stromal area from malignant tissues. CONCLUSION: The expressions of SLC10 family genes were different between normal liver tissues and malignant liver tissues, and they were correlated with each other in liver cancer. SLC10A1 possesses the most significant correlation with survival outcomes. SLC10A3 exhibited the most significant relationship with immune cells, as revealed by bioinformatics analysis and multispectral imaging technique. |
format | Online Article Text |
id | pubmed-9809167 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-98091672023-01-04 The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer Tian, Shan Li, Jiao Xiang, Jiankang Peng, Pailan J Hepatocell Carcinoma Original Research BACKGROUND AND AIM: This study was aimed to reveal the clinical relevance and immune correlation of the SLC10 family genes in liver cancer. METHODS: A comprehensive bioinformatics analysis was utilized to determine the gene expression, genetic alterations, DNA methylation, clinical significance, survival association and immune correlation of seven SLC10 family genes in liver cancer. The multiplexed immunohistochemical technique was applied to determine the association between SLC10A3 protein expression and immune cells, and the correlation between SLC10A3 protein and immune checkpoints (PD1 and PD-L1) in a cohort of 32 individuals with liver cancer. RESULTS: The expression of SLC10 family genes was different between normal liver tissues and malignant liver tissues. SLC10A5 showed the highest alteration rate (8%), followed by SLC10A3 (2.8%). Low expression of SLC10A1 was indicative of poor tumor grade and advanced tumor stage in liver cancer. Scatter plots uncovered that expression of SLC10A3 was inversely associated with SLC10A1 and SLC10A5 expression in liver cancer. The expression of SLC10A1 and SLC10A5 was strongly associated with their DNA methylation. SLC10A1 expression was a reliable genetic biomarker for the prediction of survival outcomes in liver cancer population. Expression of SLC10 family genes was remarkably linked with the abundance of most immune infiltrating cells in liver cancer, and SLC10A3 was the most significant member. The multiplexed immunohistochemical technique confirmed that there existed the significant correlations between SLC10A3 protein expression and CD4 T cells, CD20 B cells and the close association with PD-1 in the stromal area from malignant tissues. CONCLUSION: The expressions of SLC10 family genes were different between normal liver tissues and malignant liver tissues, and they were correlated with each other in liver cancer. SLC10A1 possesses the most significant correlation with survival outcomes. SLC10A3 exhibited the most significant relationship with immune cells, as revealed by bioinformatics analysis and multispectral imaging technique. Dove 2022-12-30 /pmc/articles/PMC9809167/ /pubmed/36606115 http://dx.doi.org/10.2147/JHC.S392586 Text en © 2022 Tian et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Tian, Shan Li, Jiao Xiang, Jiankang Peng, Pailan The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer |
title | The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer |
title_full | The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer |
title_fullStr | The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer |
title_full_unstemmed | The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer |
title_short | The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer |
title_sort | clinical relevance and immune correlation of slc10 family genes in liver cancer |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809167/ https://www.ncbi.nlm.nih.gov/pubmed/36606115 http://dx.doi.org/10.2147/JHC.S392586 |
work_keys_str_mv | AT tianshan theclinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer AT lijiao theclinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer AT xiangjiankang theclinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer AT pengpailan theclinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer AT tianshan clinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer AT lijiao clinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer AT xiangjiankang clinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer AT pengpailan clinicalrelevanceandimmunecorrelationofslc10familygenesinlivercancer |